6944-78-1

Usage

General Description

2-amino-3-bromo-6,7-dimethylnaphthalene-1,4-dione is a chemical compound with a naphthalene-based structure. It contains a bromine atom and a dimethyl group, along with an amino and a carbonyl group. 2-amino-3-bromo-6,7-dimethylnaphthalene-1,4-dione has potential applications in organic synthesis and pharmaceutical research, due to its unique structure and potential reactivity. It may be used as a starting material for the synthesis of various complex organic molecules, and its properties and applications make it a valuable compound in chemical research and development.

Upstream product

• 2670-18-0 6,7-dimethyl-4a,5,8,8a-tetrahydronaphthalene-1,4-dione 
• 106-51-4 p-benzoquinone 
• 513-81-5 2,3-dimethyl-buta-1,3-diene 
• 2202-79-1 6,7-dimethyl-1,4-naphthoquinone 
• 41791-77-9 2,3-dibromo-6,7-dimethyl-1,4-naphthoquinone 

Downstream Products

• 72364-90-0 2-acetamido-3-bromo-6,7-dimethyl-1,4-naphthoquinone 
• 72364-91-1 4,9-dihydro-6,7-dimethyl-4,9-dioxo-1H-naphtho-[2,3-d]-triazole 

Relevant academic research and scientific papers

Trinuclear Mn(ii) complex with paramagnetic bridging 1,2,3-dithiazolyl ligands

The first metal coordination complex of a radical ligand based on the 1,2,3-dithiazolyl heterocycle is reported. 6,7-Dimethyl-1,4-dioxo-naphtho[2,3-d] [1,2,3]dithiazolyl acts as a bridging ligand in the volatile trinuclear Mn(hfac)2-Rad-Mn(hfac)2-Rad-Mn(hfac)2 complex (hfac = 1,1,1,5,5,5-hexafluoroacetylacetonato-). The Mn(ii) and radical ligand spins are coupled anti-ferromagnetically (AF) resulting in an ST = 13/2 spin ground state.

Studies on v-triazoles. 9. Antiallergic 4,9-dihydro-4,9-dioxo-1H-naphtho[2,3-d]-v-triazoles

A short series of the title compounds was prepared and evaluated for antiallergic activity in the rat passive cutaneous anaphylaxis screen. All but the two N-methylated derivatives were active in this screen by the intravenous route, the most potent being

Polycyclic triazoles used to inhibit allergic responses

Compounds of formula (I): STR1 and pharmaceutically acceptable salts thereof wherein R1, R2, R3 and R4 which may be the same or different, represent hydrogen, halogen, nitro, lower alkyl, or lower alkoxy, or any adjacent two of R1 to R4 taken together represent an alkylene group containing from 3 to 5 carbon atoms or a 1,4-buta-1,3-dienylene group are disclosed together with a method for their preparation. The compounds are useful as anti-allergic agents. With the exception of 4,9-dioxo-1H-naphtho-[2,3-d]-triazole, and its salts, all compounds of formula (I) are novel.